SCHEMBL28359160

SCHEMBL28359160

CCC(CNc1nc(-c2cncc(F)c2)nc2c1ncn2C(C)C)c1cn(C)c2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 7/20 0.37
▸ CDK9 P50750 4/20 0.37
▸ CDK1 P06493 14/20 0.37
▸ CDK5 Q00535 10/20 0.37
▸ CCNB1 P14635 9/20 0.37
▸ CDK5R1 Q15078 8/20 0.37
▸ CCNB2 O95067 6/20 0.37
▸ CCNB3 Q8WWL7 6/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ CCNK O75909 1/20 0.35
▸ CDK12 Q9NYV4 1/20 0.35
▸ CCNE1 P24864 5/20 0.35
▸ CDK7 P50613 4/20 0.35
▸ CCNH P51946 3/20 0.35
▸ CCNT1 O60563 2/20 0.35
▸ CDK4 P11802 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20542017 0.84 AHR (0.45) CDK2CDK1CDK5CCNB1CDK5R1
SCHEMBL30579387 0.84 AHR (0.45) CDK2CDK1CDK5CCNB1CDK5R1
SCHEMBL28359163 0.82 CDK2 (0.39) CDK2CDK9CDK1CDK5CCNB1
SCHEMBL20541795 0.76 CDK1 (0.43) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2313618 0.73 CDK1 (0.47) CDK2CDK9CDK1CDK5CCNB1
SCHEMBL20558099 0.73 CDK1 (0.42) CDK2CDK9CDK1CDK5CCNB1
SCHEMBL24966401 0.73 CDK5 (0.42) CDK2CDK1CDK5CCNB1CDK5R1
SCHEMBL2358698 0.73 CCNE2 (0.56) CDK2CDK1CDK5CCNB1CDK5R1
SCHEMBL2356743 0.72 AHR (0.43) CDK2CDK1CDK5CCNB1CDK5R1
SCHEMBL2358550 0.72 CDK2 (0.44) CDK2CDK9CDK1CDK5CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110831600-A Indole AHR inhibitors and uses thereof 金恩医疗公司 2020-02-21 — — CN disclosed
Send feedback